Company / Interest Expense
Yubo International Biotech Ltd Interest Expense History
FY2015-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$105.0K
FY2020
5-year range
$105.0K / $105.0K
FY2016-FY2020
Trend
+5.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $86,000 to $105,000 over the past 2 years.
Based on SEC 10-K filings.
$105,000 in FY2020 with a 5-year CAGR of +9.4%.
Increased from $86,000 to $105,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +6.9%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2020, interest expense increased 5.0% year-over-year.
- Lowest interest expense in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2020 | $105.0K | +5.0% |
| FY2019 | $100.0K | +16.3% |
| FY2018 | $86.0K | +0.0% |
| FY2017 | $86.0K | +14.7% |
| FY2016 | $75.0K | +11.9% |
| FY2015 | $67.0K | +81.1% |